Green Thumb Industries (GTBIF) Income from Continuing Operations (2019 - 2026)
Green Thumb Industries (GTBIF) posted Income from Continuing Operations of 15047000.0 for Q1 2026, down 93.04% on a QoQ basis from 216267000.0 in Q4 2025, and up 79.11% year-over-year from 8401000.0 in Q1 2025.
Green Thumb Industries (GTBIF) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Green Thumb Industries' Income from Continuing Operations history runs 8 years deep, the most recent figure standing at 15047000.0 for Q1 2026.
- Quarterly Income from Continuing Operations rose 79.11% year-over-year to 15047000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 255847000.0 (up 63.51% YoY) and the FY2025 annual result came in at 249201000.0, up 38.89% from the prior year.
- Income from Continuing Operations was 15047000.0 for Q1 2026 at Green Thumb Industries, down from 216267000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 216267000.0 in Q4 2025 and bottomed at 98994000.0 in Q4 2022.
- A 5-year average of 31324647.06 and a median of 15047000.0 in 2026 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations tumbled 166.62% — and 2024, when it surged 233.31%.
- Green Thumb Industries' Income from Continuing Operations stood at 98994000.0 in 2022, then soared by 190.29% to 89377000.0 in 2023, then jumped by 32.44% to 118374000.0 in 2024, then jumped by 82.7% to 216267000.0 in 2025, then slumped by 93.04% to 15047000.0 in 2026.
- Business Quant data shows GTBIF's Income from Continuing Operations at 15047000.0 in Q1 2026, 216267000.0 in Q4 2025, and 23801000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 15.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.05 Mn |
| Dec 31, 2025 | 216.27 Mn |
| Sep 30, 2025 | 23.80 Mn |
| Jun 30, 2025 | 732,000.00 |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | 118.37 Mn |
| Sep 30, 2024 | 8.78 Mn |
| Jun 30, 2024 | 20.92 Mn |
| Mar 31, 2024 | 31.35 Mn |
| Dec 31, 2023 | 89.38 Mn |
| Sep 30, 2023 | 10.81 Mn |
| Jun 30, 2023 | 13.69 Mn |
| Mar 31, 2023 | 9.41 Mn |
| Dec 31, 2022 | -98.99 Mn |
| Sep 30, 2022 | 10.15 Mn |
| Jun 30, 2022 | 24.73 Mn |
| Mar 31, 2022 | 29.69 Mn |
| Dec 31, 2021 | 148.61 Mn |
| Sep 30, 2021 | 21.59 Mn |
| Jun 30, 2021 | 23.27 Mn |